REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Thursday reported a loss of $12.8 million in its third quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 14 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
The provider of oncology testing services posted revenue of $60.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $45.7 million.
Guardant Health expects full-year revenue in the range of $202 million to $207 million.
Guardant Health shares have increased 71% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $64.20, a rise of 74% in the last 12 months.